• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床耳鼻喉科人乳头瘤病毒(HPV)疫苗接种项目实施的可行性。

Feasibility of Instituting a Clinical Otolaryngology Human Papillomavirus (HPV) Vaccination Program.

机构信息

Reno School of Medicine, University of Nevada, Reno, Nevada, USA.

Department of Otorhinolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Laryngoscope. 2023 Jan;133(1):116-123. doi: 10.1002/lary.30130. Epub 2022 Apr 2.

DOI:10.1002/lary.30130
PMID:35366006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9977531/
Abstract

OBJECTIVES

To measure baseline human papillomavirus (HPV) vaccination rates among tertiary and community-based Otolaryngology - Head and Neck Surgery (Oto-HNS) clinic patients and to determine risk factors for under-vaccination.

METHODS

Retrospective chart review of patients aged 9 to 26 years presenting to an Oto-HNS clinic from 2017 to 2019. Patients were considered complete for HPV vaccination if they received two doses of HPV vaccine with the first dose received before age 15 years or three doses of HPV vaccine otherwise.

RESULTS

8,532 unique patients met the criteria. At the index visit, 3,110 (36.5%) had completed the HPV series, 5,422 (63.5%) were due for one or more doses, with 4,981 (58.4%) eligible for vaccination at the time of their appointment. Of those dues, most (3,148/5,422 or 58%) were past due by age (≥13 years old). Of the 3,148 patients past due, 745 (23.7%) were partially vaccinated and 2,403 (76.3%) were vaccine naïve. Male sex and younger age were both independently associated with incomplete vaccination (p < 0.0001).

CONCLUSION

This study demonstrates that the implementation of on-site HPV vaccination has the potential to increase the opportunities for vaccination among vaccine-eligible patients, especially among young males. Otolaryngologists have the potential to provide meaningful preventive services in the fight against HPV-mediated disease.

LEVEL OF EVIDENCE

3 Laryngoscope, 133:116-123, 2023.

摘要

目的

测量三级和社区耳鼻喉科-头颈外科(Oto-HNS)诊所患者的人乳头瘤病毒(HPV)疫苗接种基线率,并确定疫苗接种不足的危险因素。

方法

回顾性分析 2017 年至 2019 年在耳鼻喉科诊所就诊的 9 至 26 岁患者的病历。如果患者接受了两剂 HPV 疫苗接种,且第一剂在 15 岁之前接种,或接受了三剂 HPV 疫苗接种,则认为其 HPV 疫苗接种完成。

结果

共有 8532 名患者符合标准。在就诊时,3110 名(36.5%)患者已完成 HPV 系列接种,5422 名(63.5%)需要接种一剂或多剂疫苗,其中 4981 名(58.4%)在预约时符合接种条件。在这些需要接种的患者中,大多数(3148/5422 或 58%)已超过接种年龄(≥13 岁)。在 3148 名逾期未接种的患者中,745 名(23.7%)部分接种,2403 名(76.3%)未接种疫苗。男性和年龄较小均与接种不完全独立相关(p<0.0001)。

结论

本研究表明,现场 HPV 疫苗接种的实施有可能增加疫苗接种机会,特别是在年轻男性中。耳鼻喉科医生有潜力在抗击 HPV 介导疾病的斗争中提供有意义的预防服务。

证据水平

3 Laryngoscope, 133:116-123, 2023.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/20d751b4a3a1/nihms-1873905-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/05b8c4bfc0ad/nihms-1873905-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/39c5b89f6c57/nihms-1873905-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/20d751b4a3a1/nihms-1873905-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/05b8c4bfc0ad/nihms-1873905-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/39c5b89f6c57/nihms-1873905-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bad5/9977531/20d751b4a3a1/nihms-1873905-f0003.jpg

相似文献

1
Feasibility of Instituting a Clinical Otolaryngology Human Papillomavirus (HPV) Vaccination Program.临床耳鼻喉科人乳头瘤病毒(HPV)疫苗接种项目实施的可行性。
Laryngoscope. 2023 Jan;133(1):116-123. doi: 10.1002/lary.30130. Epub 2022 Apr 2.
2
Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.对澳大利亚年轻女性进行了八年全国疫苗接种计划后,评估生殖器人乳头瘤病毒基因流行率的研究的最终分析。
Vaccine. 2018 May 31;36(23):3221-3230. doi: 10.1016/j.vaccine.2018.04.080. Epub 2018 Apr 30.
3
Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.澳大利亚实施女性和男性基于学校的疫苗接种后青少年异性恋男性中人类乳头瘤病毒的流行情况:2014-2017 年。
Vaccine. 2019 Oct 31;37(46):6907-6914. doi: 10.1016/j.vaccine.2019.09.052. Epub 2019 Sep 24.
4
Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.2017 年至 2019 年,在加拿大三个最大城市招募的男同性恋、双性恋和其他男男性行为者社区样本中,人乳头瘤病毒(HPV)疫苗接种率。
Vaccine. 2021 Jun 23;39(28):3756-3766. doi: 10.1016/j.vaccine.2021.05.031. Epub 2021 May 29.
5
Postpartum HPV Vaccination Rate and Differences in Background Characteristics Between HPV Vaccinated and Unvaccinated Postpartum Women: Strict Monitoring and Follow-Up of Postpartum HPV Vaccination Program.产后 HPV 疫苗接种率及 HPV 疫苗接种和未接种产后妇女的背景特征差异:对产后 HPV 疫苗接种计划进行严格监测和随访。
Front Immunol. 2021 May 12;12:626582. doi: 10.3389/fimmu.2021.626582. eCollection 2021.
6
Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.在加拿大魁北克省实施基于学校的和补充性疫苗接种后,年轻女性中疫苗型 HPV 感染的流行率较低。
Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123. doi: 10.1080/21645515.2017.1385688. Epub 2017 Dec 13.
7
Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.基于人群的 HPV 疫苗接种计划对宫颈异常的影响:一项数据关联研究。
BMC Med. 2013 Oct 22;11:227. doi: 10.1186/1741-7015-11-227.
8
Understanding Barriers to HPV Vaccination: Perspectives From Air Force Family Medicine Physicians and Active Duty Air Force Males.了解 HPV 疫苗接种障碍:来自空军家庭医学医师和现役空军男性的观点。
Mil Med. 2020 Jun 8;185(5-6):e878-e886. doi: 10.1093/milmed/usz403.
9
Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine.测量提供者对免疫指南的遵从度:一项关于记录 HPV 疫苗接种患者拒绝情况的混合方法研究的可行性
BMC Med Inform Decis Mak. 2022 Dec 22;22(1):339. doi: 10.1186/s12911-022-02083-2.
10
Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.测量青少年人乳头瘤病毒疫苗接种率:性传播疾病诊所与免疫登记数据的匹配
J Adolesc Health. 2016 Dec;59(6):710-715. doi: 10.1016/j.jadohealth.2016.07.021. Epub 2016 Sep 23.

引用本文的文献

1
A Qualitative Study of Attitudes Toward HPV Vaccine Recommendation in Otolaryngology Clinics.一项关于耳鼻喉科诊所对人乳头瘤病毒(HPV)疫苗推荐态度的定性研究。
Laryngoscope Investig Otolaryngol. 2025 Jan 21;10(1):e70085. doi: 10.1002/lio2.70085. eCollection 2025 Feb.
2
Diagnostics of HNSCC Patients: An Analysis of Cell Lines and Patient-Derived Xenograft Models for Personalized Therapeutical Medicine.头颈部鳞状细胞癌患者的诊断:用于个性化治疗药物的细胞系和患者来源异种移植模型分析
Diagnostics (Basel). 2022 Apr 25;12(5):1071. doi: 10.3390/diagnostics12051071.

本文引用的文献

1
Assessing Human Papillomavirus Awareness and the Role of Oropharyngeal Squamous Cell Carcinoma Education on Improving Intention to Vaccinate.评估人乳头瘤病毒(HPV)知晓率及口咽鳞状细胞癌教育对提高 HPV 疫苗接种意愿的作用。
Laryngoscope. 2022 Mar;132(3):528-537. doi: 10.1002/lary.29805. Epub 2021 Aug 12.
2
Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.与初级保健网络中青少年患者接受人乳头瘤病毒(HPV)疫苗相关的患者和临床医生因素。
Vaccine. 2021 Jun 11;39(26):3528-3535. doi: 10.1016/j.vaccine.2021.04.055. Epub 2021 May 19.
3
Provider communication and HPV vaccine uptake: A meta-analysis and systematic review.
提供者沟通与 HPV 疫苗接种率:荟萃分析与系统评价。
Prev Med. 2021 Jul;148:106554. doi: 10.1016/j.ypmed.2021.106554. Epub 2021 Apr 20.
4
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.2019 年美国 13-17 岁青少年的国家、地区、州和选定局部地区疫苗接种覆盖率。
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116. doi: 10.15585/mmwr.mm6933a1.
5
Human Papillomavirus-Attributable Cancers - United States, 2012-2016.人乳头瘤病毒相关癌症 - 美国,2012-2016 年。
MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):724-728. doi: 10.15585/mmwr.mm6833a3.
6
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.人乳头瘤病毒疫苗接种:免疫实践咨询委员会的最新建议。
MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702. doi: 10.15585/mmwr.mm6832a3.
7
Practice patterns and knowledge among California pediatricians regarding human papillomavirus and its relation to head and neck cancer.加利福尼亚州儿科医生在人乳头瘤病毒及其与头颈部癌症的关系方面的实践模式和知识。
Am J Otolaryngol. 2019 Jul-Aug;40(4):525-529. doi: 10.1016/j.amjoto.2019.04.011. Epub 2019 Apr 25.
8
Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015.人乳头瘤病毒相关性癌症趋势 - 美国,1999-2015 年。
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):918-924. doi: 10.15585/mmwr.mm6733a2.
9
Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic.临床干预措施包对妇产科诊所 HPV 疫苗接种率的影响。
Vaccine. 2018 Jun 14;36(25):3599-3605. doi: 10.1016/j.vaccine.2018.05.039. Epub 2018 May 11.
10
Missed opportunities for HPV immunization among young adult women.年轻女性中 HPV 疫苗接种的错失机会。
Am J Obstet Gynecol. 2018 Mar;218(3):326.e1-326.e7. doi: 10.1016/j.ajog.2017.11.602. Epub 2017 Dec 6.